Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001445305-14-005107
Filing Date
2014-11-13
Accepted
2014-11-13 16:26:29
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q imdz930201410-q.htm 10-Q 935758
2 EXHIBIT 31.1 ex311imdz2014q3.htm EX-31.1 7454
3 EXHIBIT 31.2 ex312imdz2014q3.htm EX-31.2 7938
4 EXHIBIT 32.1 ex321imdz2014q3.htm EX-32.1 4691
5 EXHIBIT 32.2 ex322imdz2014q3.htm EX-32.2 4927
  Complete submission text file 0001445305-14-005107.txt   5052564

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imdz-20140930.xml EX-101.INS 733052
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imdz-20140930.xsd EX-101.SCH 30417
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imdz-20140930_cal.xml EX-101.CAL 45666
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imdz-20140930_def.xml EX-101.DEF 145007
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imdz-20140930_lab.xml EX-101.LAB 424183
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imdz-20140930_pre.xml EX-101.PRE 251945
Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Filer) CIK: 0001437786 (see all company filings)

EIN.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36561 | Film No.: 141218763
SIC: 2834 Pharmaceutical Preparations